Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTreatt Regulatory News (TET)

Share Price Information for Treatt (TET)

Share Price is delayed by 15 minutes
Get Live Data
301.50    -0.50 (-0.17%)
Bid:
302.00
Ask:
302.50
Spread: 0.50 (0.166%)
Market Cap: £177.99m
TET Live PriceLast checked at - London Stock Exchange

Intraday Treatt Share Chart

Trading Statement

28 May 2013 07:00

RNS Number : 5956F
Treatt PLC
28 May 2013
 

28 May 2013

 

TREATT PLC

TRADING UPDATE FOR YEAR ENDING 30 SEPTEMBER 2013

Treatt PLC (the 'Group'), the manufacturer and supplier of conventional, organic and fair traded ingredient solutions for the flavour, fragrance and consumer goods industries today issues the following trading update for the year ending 30 September 2013.

Following the recent announcement of our half year results, which showed pre-tax profits up 30% and EPS up 40%, momentum in the business has continued to build towards a very strong Q3. We are delighted to report that Group sales for May 2013 are expected to reach an all-time high and order books for the remainder of Q3 and for Q4 now look promising. This positive commercial environment, coupled with the continuing impact of the Board's new strategy, and the lower overheads and improved margins it is delivering, means that the Board expects the Group to exceed its expectations for the current financial year ending 30 September 2013.

 

Looking further ahead, the strategic creation of a global sales structure, which is clearly focused on selling value-added ingredient solutions with its emphasis on multi-national consumer goods companies, is already leading to significant new opportunities for growth. We are particularly focused on developing new and exciting products for the beverage sector where the possibilities for growing sales are material. The continuing transition of product mix towards added-value manufactured ingredients should enable the Group to target higher margin business. The Board believes that this, coupled with significant cost saving measures, some of which have already been implemented but have not yet delivered their full-year impact, should deliver the long-term sustainable growth in earnings intended.

 

Consequently, the Board believes that the momentum now in the business and the benefits from the initiatives outlined above will extend beyond the current financial year and that the prospects for the business for the years ending 30 September 2014 and 2015 are also improved.

 

The Company intends to release its Interim Management Statement for the second half year in July 2013 and the full year results for the current financial year will be announced on 9 December 2013.

 

For further information please contact:

 

Tim Jones

Chairman

 

Daemmon Reeve

Chief Executive Officer

 

Richard Hope

Group Finance Director

01284 702500

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTZMGZKNDVGFZM
Date   Source Headline
7th May 20197:00 amRNSHalf-year Report
5th Apr 20197:00 amRNSTrading Update
25th Mar 20195:51 pmRNSDirector/PDMR Shareholding
25th Mar 20195:51 pmRNSDirector/PDMR Shareholding
15th Mar 20194:10 pmRNSDirector/PDMR Shareholding
6th Mar 20199:27 amRNSDirector/PDMR Shareholding
6th Feb 20191:10 pmRNSBoard Appointments
25th Jan 20194:14 pmRNSResult of AGM
17th Jan 20195:05 pmRNSDirector/PDMR Shareholding
11th Jan 20195:09 pmRNSDirector/PDMR Shareholding
7th Jan 20192:45 pmRNSDirector/PDMR Shareholding
31st Dec 20187:30 amRNSTotal Voting Rights
19th Dec 20184:51 pmRNSDirector/PDMR Shareholding
18th Dec 20183:53 pmRNSDirector/PDMR Shareholding
17th Dec 20189:16 amRNSHolding(s) in Company
10th Dec 20189:16 amRNSHolding(s) in Company
7th Dec 201811:22 amRNSAnnual Report
4th Dec 20183:58 pmRNSHolding(s) in Company
3rd Dec 201812:06 pmRNSBlock Listing Six Monthly Return
27th Nov 20187:00 amRNSFinal Results
16th Nov 201812:07 pmRNSSecond Price Monitoring Extn
16th Nov 201812:02 pmRNSPrice Monitoring Extension
14th Nov 201812:13 pmRNSHolding(s) in Company
13th Nov 20184:35 pmRNSPrice Monitoring Extension
9th Nov 20184:40 pmRNSSecond Price Monitoring Extn
9th Nov 20184:35 pmRNSPrice Monitoring Extension
6th Nov 20183:44 pmRNSHolding(s) in Company
16th Oct 20189:30 amRNSBoard Change
12th Oct 201812:07 pmRNSSecond Price Monitoring Extn
12th Oct 201812:02 pmRNSPrice Monitoring Extension
10th Oct 201812:07 pmRNSSecond Price Monitoring Extn
10th Oct 201812:02 pmRNSPrice Monitoring Extension
8th Oct 201812:07 pmRNSSecond Price Monitoring Extn
8th Oct 201812:02 pmRNSPrice Monitoring Extension
2nd Oct 20185:30 pmRNSDirector/PDMR Shareholding
2nd Oct 20187:00 amRNSTrading Update
1st Oct 20184:51 pmRNSTotal Voting Rights
7th Sep 20184:35 pmRNSPrice Monitoring Extension
3rd Sep 20184:18 pmRNSDirector/PDMR Shareholding
3rd Sep 20188:58 amRNSHolding(s) in Company
23rd Aug 20184:19 pmRNSDirector/PDMR Shareholding
20th Aug 20181:41 pmRNSDirector/PDMR Shareholding
8th Aug 20184:00 pmRNSHolding(s) in Company
10th Jul 20184:52 pmRNSHolding(s) in Company
9th Jul 20183:32 pmRNSDirector/PDMR Shareholding
5th Jul 201812:11 pmRNSHolding(s) in Company
4th Jul 201812:08 pmRNSTotal Voting Rights
13th Jun 201810:14 amRNSDirector/PDMR Shareholding
11th Jun 20184:47 pmRNSHolding(s) in Company
8th Jun 20187:00 amRNSBlock Listing Application

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.